TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Polypeptide Laboratories Holding (PPL) AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,733,805
|
1,325,018
|
892,176 |
| Financial expenses |
125,451
|
43,574
|
17,324 |
| Earnings before taxes |
-332,114
|
-211,748
|
-46,762 |
| EBITDA |
-571,055
|
-167,751
|
-18,133 |
| Total assets |
4,385,450
|
2,993,944
|
2,025,398 |
| Current assets |
1,496,473
|
580,658
|
428,237 |
| Current liabilities |
1,309,339
|
849,961
|
830,561 |
| Equity capital |
414,336
|
547,704
|
499,774 |
| - share capital |
200
|
200
|
185 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
9.4%
|
18.3%
|
24.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-19.2%
|
-16.0%
|
-5.2% |
| Return on assets (ROA) |
-4.7%
|
-5.6%
|
-1.5% |
| Current ratio |
114.3%
|
68.3%
|
51.6% |
| Return on equity (ROE) |
-80.2%
|
-38.7%
|
-9.4% |
| Change turnover |
408,787
|
432,842
|
182,922 |
| Change turnover % |
31%
|
49%
|
26% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.